Compare $ONCO vs $VCNX | Chartloom

Compare

$ONCO vs $VCNX

Onconetix Inc · Vaccinex Inc

ONCO

Onconetix Inc

VCNX

Vaccinex Inc

Compare $ONCO vs $VCNX

Comparing Onconetix Inc and Vaccinex Inc

ONCOOnconetix Inc

VCNXVaccinex Inc

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ONCO

VCNX

Detailed metrics comparison

ONCO

Onconetix Inc

VCNX

Vaccinex Inc

Market Cap

ONCO$2M

VCNX$3M

Enterprise Value

ONCO$-3M

VCNX$2M

Price

ONCO$0.62

VCNX$1.14

P/E Ratio

ONCON/A

VCNXN/A

P/S Ratio

ONCO3.79x

VCNX5.08x

EV/Sales

ONCO-5.18x

VCNX3.28x

EV/EBITDA

ONCO0.00x

VCNX0.00x

P/B Ratio

ONCO0.24x

VCNX1.15x

P/FCF Ratio

ONCON/A

VCNXN/A

EV/FCF

ONCO0.32x

VCNX-0.12x

PEG Ratio

ONCON/A

VCNXN/A

Forward P/E (NTM)

ONCON/A

VCNXN/A

Forward P/S (NTM)

ONCON/A

VCNXN/A

Revenue (TTM)

ONCO$646K

VCNX$601K

Revenue Growth (YoY)

ONCO-51.3%

VCNX5.4%

Forward Rev Growth

ONCO0.0%

VCNX0.0%

Gross Margin (TTM)

ONCO80.4%

VCNX99.7%

Operating Margin (TTM)

ONCO0.0%

VCNX0.0%

EBITDA Margin (TTM)

ONCO-1188.1%

VCNX-3101.7%

Net Margin (TTM)

ONCO-1578.8%

VCNX-3100.5%

FCF Margin (TTM)

ONCO-1596.2%

VCNX-2696.8%

Net Income (TTM)

ONCO$-10M

VCNX$-19M

FCF (TTM)

ONCO$-10M

VCNX$-16M

EPS (TTM)

ONCO-$4.55

VCNX-$5.78

ROE (TTM)

ONCO-9194.0%

VCNX-14678.0%

ROA (TTM)

ONCO-5376.0%

VCNX-43375.0%

ROIC (TTM)

ONCO-9080.0%

VCNX-14238.0%

Cash

ONCO$6M

VCNX$1M

Debt

ONCO$150K

VCNX$25K

Net Cash/Debt

ONCO$6M

VCNX$1M

Current Ratio (TTM)

ONCO2.21x

VCNX0.50x

Quick Ratio (TTM)

ONCO2.04x

VCNX0.38x

Debt/Equity (TTM)

ONCO0.01x

VCNX0.03x

Debt/Assets (TTM)

ONCO0.0%

VCNX0.0%

Interest Coverage (TTM)

ONCON/A

VCNXN/A

Net Debt/EBITDA (TTM)

ONCO0.00x

VCNX0.00x

Beta

ONCO2.60

VCNX0.73

52W Performance

ONCO-99.7%

VCNX29.8%

YTD Performance

ONCO-99.2%

VCNX0.9%

% from 52W High

ONCO-99.7%

VCNX-24.0%

% from 52W Low

ONCO6.9%

VCNX267.7%

Asset Turnover (TTM)

ONCO0.03x

VCNX0.14x

FCF Yield (TTM)

ONCO-420.9%

VCNX-530.5%

Earnings Yield (TTM)

ONCO-416.3%

VCNX-609.9%

Dividend Yield (TTM)

ONCON/A

VCNXN/A

Rule of 40

ONCO-1,647.5

VCNX-2,691.4

EV/GP/RG

ONCON/A

VCNXN/A

Ticker research

View ONCO research View VCNX research

Metric	ONCO Onconetix Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-3M	$2M
Price	$0.62	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	3.79x	5.08x
EV/Sales	-5.18x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.24x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	0.32x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$646K	$601K
Revenue Growth (YoY)	-51.3%	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	80.4%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1188.1%	-3101.7%
Net Margin (TTM)	-1578.8%	-3100.5%
FCF Margin (TTM)	-1596.2%	-2696.8%
Net Income (TTM)	$-10M	$-19M
FCF (TTM)	$-10M	$-16M
EPS (TTM)	-$4.55	-$5.78
ROE (TTM)	-9194.0%	-14678.0%
ROA (TTM)	-5376.0%	-43375.0%
ROIC (TTM)	-9080.0%	-14238.0%
Financial Health
Cash	$6M	$1M
Debt	$150K	$25K
Net Cash/Debt	$6M	$1M
Current Ratio (TTM)	2.21x	0.50x
Quick Ratio (TTM)	2.04x	0.38x
Debt/Equity (TTM)	0.01x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	0.73
52W Performance	-99.7%	29.8%
YTD Performance	-99.2%	0.9%
% from 52W High	-99.7%	-24.0%
% from 52W Low	6.9%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.14x
FCF Yield (TTM)	-420.9%	-530.5%
Earnings Yield (TTM)	-416.3%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,647.5	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View ONCO research	View VCNX research

Valuation

P/S Ratio

ONCO

3.79x

VCNX

5.08x

EV/FCF

VCNX

-0.12x

ONCO

0.32x

Growth & revenue

Revenue Growth TTM

VCNX

5.4%

ONCO

-51.3%

Forward Revenue Growth

ONCO

0.0%

VCNX

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

ONCO

80.4%

ROE

ONCO

-9194.0%

VCNX

-14678.0%

FCF Yield %

ONCO

-420.9%

VCNX

-530.5%

52-Week Performance

VCNX

29.8%

ONCO

-99.7%

Detailed metrics comparison

ONCO

Onconetix Inc

VCNX

Vaccinex Inc

Market Cap

ONCO$2M

VCNX$3M

Enterprise Value

ONCO$-3M

VCNX$2M

Price

ONCO$0.62

VCNX$1.14

P/E Ratio

ONCON/A

VCNXN/A

P/S Ratio

ONCO3.79x

VCNX5.08x

EV/Sales

ONCO-5.18x

VCNX3.28x

EV/EBITDA

ONCO0.00x

VCNX0.00x

P/B Ratio

ONCO0.24x

VCNX1.15x

P/FCF Ratio

ONCON/A

VCNXN/A

EV/FCF

ONCO0.32x

VCNX-0.12x

PEG Ratio

ONCON/A

VCNXN/A

Forward P/E (NTM)

ONCON/A

VCNXN/A

Forward P/S (NTM)

ONCON/A

VCNXN/A

Revenue (TTM)

ONCO$646K

VCNX$601K

Revenue Growth (YoY)

ONCO-51.3%

VCNX5.4%

Forward Rev Growth

ONCO0.0%

VCNX0.0%

Gross Margin (TTM)

ONCO80.4%

VCNX99.7%

Operating Margin (TTM)

ONCO0.0%

VCNX0.0%

EBITDA Margin (TTM)

ONCO-1188.1%

VCNX-3101.7%

Net Margin (TTM)

ONCO-1578.8%

VCNX-3100.5%

FCF Margin (TTM)

ONCO-1596.2%

VCNX-2696.8%

Net Income (TTM)

ONCO$-10M

VCNX$-19M

FCF (TTM)

ONCO$-10M

VCNX$-16M

EPS (TTM)

ONCO-$4.55

VCNX-$5.78

ROE (TTM)

ONCO-9194.0%

VCNX-14678.0%

ROA (TTM)

ONCO-5376.0%

VCNX-43375.0%

ROIC (TTM)

ONCO-9080.0%

VCNX-14238.0%

Cash

ONCO$6M

VCNX$1M

Debt

ONCO$150K

VCNX$25K

Net Cash/Debt

ONCO$6M

VCNX$1M

Current Ratio (TTM)

ONCO2.21x

VCNX0.50x

Quick Ratio (TTM)

ONCO2.04x

VCNX0.38x

Debt/Equity (TTM)

ONCO0.01x

VCNX0.03x

Debt/Assets (TTM)

ONCO0.0%

VCNX0.0%

Interest Coverage (TTM)

ONCON/A

VCNXN/A

Net Debt/EBITDA (TTM)

ONCO0.00x

VCNX0.00x

Beta

ONCO2.60

VCNX0.73

52W Performance

ONCO-99.7%

VCNX29.8%

YTD Performance

ONCO-99.2%

VCNX0.9%

% from 52W High

ONCO-99.7%

VCNX-24.0%

% from 52W Low

ONCO6.9%

VCNX267.7%

Asset Turnover (TTM)

ONCO0.03x

VCNX0.14x

FCF Yield (TTM)

ONCO-420.9%

VCNX-530.5%

Earnings Yield (TTM)

ONCO-416.3%

VCNX-609.9%

Dividend Yield (TTM)

ONCON/A

VCNXN/A

Rule of 40

ONCO-1,647.5

VCNX-2,691.4

EV/GP/RG

ONCON/A

VCNXN/A

Ticker research

View ONCO research View VCNX research

Metric	ONCO Onconetix Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-3M	$2M
Price	$0.62	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	3.79x	5.08x
EV/Sales	-5.18x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.24x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	0.32x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$646K	$601K
Revenue Growth (YoY)	-51.3%	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	80.4%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1188.1%	-3101.7%
Net Margin (TTM)	-1578.8%	-3100.5%
FCF Margin (TTM)	-1596.2%	-2696.8%
Net Income (TTM)	$-10M	$-19M
FCF (TTM)	$-10M	$-16M
EPS (TTM)	-$4.55	-$5.78
ROE (TTM)	-9194.0%	-14678.0%
ROA (TTM)	-5376.0%	-43375.0%
ROIC (TTM)	-9080.0%	-14238.0%
Financial Health
Cash	$6M	$1M
Debt	$150K	$25K
Net Cash/Debt	$6M	$1M
Current Ratio (TTM)	2.21x	0.50x
Quick Ratio (TTM)	2.04x	0.38x
Debt/Equity (TTM)	0.01x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	0.73
52W Performance	-99.7%	29.8%
YTD Performance	-99.2%	0.9%
% from 52W High	-99.7%	-24.0%
% from 52W Low	6.9%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.14x
FCF Yield (TTM)	-420.9%	-530.5%
Earnings Yield (TTM)	-416.3%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,647.5	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View ONCO research	View VCNX research